The validation study showed that SOX3 is overexpressed in cancer tissues, and its levels are associated with poor outcomes for stomach cancer, and that SOX3 promotes gastric cancer cell invasion and migration through MMP9. This evidence concerns the gene MMP9 and gastric cancer.